BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29950273)

  • 1. Correlates of immune exacerbations in leprosy.
    Geluk A
    Semin Immunol; 2018 Oct; 39():111-118. PubMed ID: 29950273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.
    Khadge S; Banu S; Bobosha K; van der Ploeg-van Schip JJ; Goulart IM; Thapa P; Kunwar CB; van Meijgaarden KE; van den Eeden SJ; Wilson L; Kabir S; Dey H; Goulart LR; Lobato J; Carvalho W; Bekele Y; Franken KL; Aseffa A; Spencer JS; Oskam L; Otttenhoff TH; Hagge DA; Geluk A
    BMC Infect Dis; 2015 Oct; 15():477. PubMed ID: 26510990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Related Laboratory Parameters for Leprosy Reactions.
    Luo Y; Kiriya M; Tanigawa K; Kawashima A; Nakamura Y; Ishii N; Suzuki K
    Front Med (Lausanne); 2021; 8():694376. PubMed ID: 34746168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.
    Geluk A; van Meijgaarden KE; Wilson L; Bobosha K; van der Ploeg-van Schip JJ; van den Eeden SJ; Quinten E; Dijkman K; Franken KL; Haisma EM; Haks MC; van Hees CL; Ottenhoff TH
    J Clin Immunol; 2014 Feb; 34(2):245-55. PubMed ID: 24370984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh.
    Richardus RA; van der Zwet K; van Hooij A; Wilson L; Oskam L; Faber R; van den Eeden SJF; Pahan D; Alam K; Richardus JH; Geluk A
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006083. PubMed ID: 29228004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
    Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
    BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of protein antigens for early serological diagnosis of leprosy.
    Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
    Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in immunodiagnostic tests for leprosy.
    Geluk A
    Expert Opin Med Diagn; 2013 May; 7(3):265-74. PubMed ID: 23537134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field-Friendly Test for Monitoring Multiple Immune Response Markers during Onset and Treatment of Exacerbated Immunity in Leprosy.
    Corstjens PLAM; van Hooij A; Tjon Kon Fat EM; van den Eeden SJF; Wilson L; Geluk A
    Clin Vaccine Immunol; 2016 Jun; 23(6):515-519. PubMed ID: 27030588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study.
    TiĆ³-Coma M; van Hooij A; Bobosha K; van der Ploeg-van Schip JJ; Banu S; Khadge S; Thapa P; Kunwar CB; Goulart IM; Bekele Y; Hagge DA; Moraes MO; Teles RMB; Pinheiro RO; van Zwet EW; Goeman JJ; Aseffa A; Haks MC; Ottenhoff THM; Modlin RL; Geluk A
    Sci Rep; 2019 Nov; 9(1):17931. PubMed ID: 31784594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of new host biomarker profiles in quantitative point-of-care tests facilitates leprosy diagnosis in the field.
    van Hooij A; van den Eeden S; Richardus R; Tjon Kon Fat E; Wilson L; Franken KLMC; Faber R; Khatun M; Alam K; Sufian Chowdhury A; Richardus JH; Corstjens P; Geluk A
    EBioMedicine; 2019 Sep; 47():301-308. PubMed ID: 31422044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for leprosy: would you prefer T (cells)?
    Geluk A
    Lepr Rev; 2013 Mar; 84(1):3-12. PubMed ID: 23741878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.
    Pinheiro RO; de Souza Salles J; Sarno EN; Sampaio EP
    Future Microbiol; 2011 Feb; 6(2):217-30. PubMed ID: 21366421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease.
    Geluk A; Duthie MS; Spencer JS
    Lepr Rev; 2011 Dec; 82(4):402-21. PubMed ID: 22439280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oral cavity in leprosy: what clinicians need to know.
    Rodrigues GA; Qualio NP; de Macedo LD; Innocentini L; Ribeiro-Silva A; Foss NT; Frade M; Motta A
    Oral Dis; 2017 Sep; 23(6):749-756. PubMed ID: 27606832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy.
    Singh I; Yadav AR; Mohanty KK; Katoch K; Bisht D; Sharma P; Sharma B; Gupta UD; Sengupta U
    Cell Immunol; 2012; 278(1-2):63-75. PubMed ID: 23121977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.